South African generic drug manufacturer Cipla Medpro Monday said its relationship with Mumbai-based pharmaceutical major Cipla India was in shareholders' interest, which would be hurt if it was taken over by rival Adcock Ingram.8:03 PM on May 05
Be the first to comment...
Add Your Comment